Humana Inc. (NYSE:HUM) shares dropped premarket after its 2026 earnings forecast of “at least $9.00” per share fell significantly below analyst expectations of $12.00, despite better-than-expected fourth-quarter 2025 results. The company reported an adjusted net loss of -$3.96 per share and revenue of $32.52 billion for Q4 2025. Humana expects approximately 25% growth in individual Medicare Advantage membership for 2026 and highlighted growth in its CenterWell platform.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Humana shares fall as 2026 earnings guidance disappoints investors By Investing.com
Humana Inc. (NYSE:HUM) shares dropped premarket after its 2026 earnings forecast of “at least $9.00” per share fell significantly below analyst expectations of $12.00, despite better-than-expected fourth-quarter 2025 results. The company reported an adjusted net loss of -$3.96 per share and revenue of $32.52 billion for Q4 2025. Humana expects approximately 25% growth in individual Medicare Advantage membership for 2026 and highlighted growth in its CenterWell platform.